| Preview
Full Doc
 | 2006 |
Asset Purchase Agreement
Asset Purchase Agreement (190K)
Doc #1244177: Click preview link for longer preview.
ASSET PURCHASE AGREEMENT
between
BRISTOL-MYERS SQUIBB COMPANY
as Seller
and
WARNER CHILCOTT COMPANY, INC.
as Purchaser
Dated as of September 30, 2005
TABLE OF CONTENTS
Page
ARTICLE I. SALE AND PURCHASE OF ASSETS
1
SECTION 1.01.
Purchase and Sale
1
SECTION 1.02.
Transfer of Assets
1
SECTION 1.03.
Assumed Liabilities
3
SECTION 1.04.
Closing. . . .
1244177
| | |
| Full Doc
 | 2005 |
BYE - Laws
BYE - Laws (92K)
Doc #1244186: This document is immediately available for purchase, but does not have a preview available for viewing.
1244186
| | |
| Preview
Full Doc
 | 2005 |
Bylaws
Bylaws (23K)
Doc #1244198: Click preview link for longer preview.
WARNER CHILCOTT, INC.
BY-LAWS
ARTICLE I
OFFICES
Section 1. The registered office shall be located in the City of Wilmington, County of New Castle, State of Delaware.
Section 2. The corporation may also have offices at such other places both within and without the State of Delaware, as the board of directors may from time to time determine or the business of the corporation may require.
ARTICLE II
ANNUAL MEETINGS OF SHAREHOLDERS
Section 1. All meetings of shareholders for the election of . . .
1244198
| | |
| Full Doc
 | 2005 |
Certificate of Incorporation
Certificate of Incorporation (1K)
Doc #1244184: This document is immediately available for purchase, but does not have a preview available for viewing.
1244184
| | |
| Preview
Full Doc
 | 2005 |
Credit Agreement
Credit Agreement (518K)
Doc #1244214: Click preview link for longer preview.
$1,790,000,000
CREDIT AGREEMENT
Dated as of January 18, 2005
among
WARNER CHILCOTT HOLDINGS COMPANY III, LIMITED
as BR Borrower
WARNER CHILCOTT CORPORATION
as US Borrower
WARNER CHILCOTT COMPANY, INC.
as PR Borrower
CREDIT SUISSE FIRST BOSTON
as Administrative Agent, Swing Line Lender and L/C Issuer
THE OTHER LENDERS PARTY HERETO
DEUTSCHE BANK SECURITIES INC.
CREDIT SUISSE FIRST BOSTON
as Joint Lead Arrangers
DEUTSCHE BANK SECURITIES INC.
CREDIT SUISSE FIRST . . .
1244214
|
McGraw-Hill Companies
As referenced in this Credit Agreement:
McGraw-Hill Companies, Inc – Lender to such Revolving Credit Borrower.
Rollover Amount has the meaning specified in Section 7.17(b).
S&P means Standard & Poors Ratings Services, a division of The McGraw-Hill Companies, Inc ., and any successor thereto.
Scheme means the proposed scheme of arrangement under Article 418 of the Companies Order to effect the Acquisition, the material terms and conditions of which _____________
dt 1517325
;
ISDA
As referenced in this Credit Agreement:
International Swaps and Derivatives Association – and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association , Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a Master Agreement), including any such obligations or _____________
dt 1602811
;
|
Bank of Ireland
As referenced in this Credit Agreement:
Bank of Ireland – time to time, among the PR Borrower, the Target, the guarantors listed therein, the lenders listed therein, ABN Amro N.V., Barclays Capital and The Governor and Company of the Bank of Ireland as mandated lead arrangers and The Governor and Company of the Bank of Ireland, as facility agent.
Facility means the Term Loan Facility, the Revolving Credit Facility, the Swing Line _____________
Bank of Ireland, – lenders listed therein, ABN Amro N.V., Barclays Capital and The Governor and Company of the Bank of Ireland as mandated lead arrangers and The Governor and Company of the Bank of Ireland, as facility agent.
Facility means the Term Loan Facility, the Revolving Credit Facility, the Swing Line Sublimit or the Letter of Credit Sublimit, as the context may require.
Fajardo _____________
dt 1508755
;
BNY
As referenced in this Credit Agreement:
Bank of New York – average of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers on such day, as published by the Federal Reserve Bank of New York on the Business Day next succeeding such day; provided that (a) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate _____________
dt 1586817
;
More... |
| Preview
Full Doc
 | 2005 |
Employment Agreement
Employment Agreement (47K)
Doc #1244237: Click preview link for longer preview.
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT (the �Agreement�) is made as of April 1, 2005, between WARNER CHILCOTT (US), INC (formerly named Warner Chilcott, Inc., the �Company�), and Paul Herendeen (�Executive�).
RECITALS
WHEREAS, Executive and the Company desire to enter into this Agreement, which Agreement will set forth the terms and conditions upon which Executive will serve as Executive Vice President-Chief Financial Officer and Executive Vice President of the Company�s ultimate parent company, Warner Chilcott Holdings Company, Limited, an . . .
1244237
|
Citibank
As referenced in this Employment Agreement:
Citibank N.A. – hereunder that is not made in a timely manner shall bear interest at a rate equal to the prime rate quoted on the date the payment is first overdue by Citibank N.A. , New York, New York plus two percent until paid.
(k) As a result of the uncertainty in the application of Section 280G of the Code at the time of _____________
dt 1479489
;
|
Citibank
As referenced in this Employment Agreement:
Citibank N.A. – hereunder that is not made in a timely manner shall bear interest at a rate equal to the prime rate quoted on the date the payment is first overdue by Citibank N.A. , New York, New York plus two percent until paid.
(k) As a result of the uncertainty in the application of Section 280G of the Code at the time of _____________
dt 1479489
|
| Preview
Full Doc
 | 2006 |
First Supplemental Indenture
First Supplemental Indenture (10K)
Doc #2563748: Click preview link for longer preview.
WARNER CHILCOTT CORPORATION
as the Issuer
The Guarantors Named Herein
and
WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Trustee
FIRST SUPPLEMENTAL INDENTURE
Dated as of October 19, 2006
8 3/4% Senior Notes due 2015
This Supplemental Indenture, dated as of October 19, 2006 (this �Supplemental Indenture� or �Guarantee�), among Warner Chilcott Limited (the �Guarantor�), Warner Chilcott Corporation (together with its successors and assigns, the �Company�), each other then existing Guarantor under the Indenture referred to below (the �Notes . . .
2563748
| | |
| Preview
Full Doc
 | 2006 |
First Supplemental Indenture
First Supplemental Indenture (10K)
Doc #2563776: Click preview link for longer preview.
WARNER CHILCOTT CORPORATION
as the Issuer
The Guarantors Named Herein
and
WELLS FARGO BANK, NATIONAL ASSOCIATION,
as Trustee
FIRST SUPPLEMENTAL INDENTURE
Dated as of October 19, 2006
8 3/4% Senior Notes due 2015
This Supplemental Indenture, dated as of October 19, 2006 (this �Supplemental Indenture� or �Guarantee�), among Warner Chilcott Limited (the �Guarantor�), Warner Chilcott Corporation (together with its successors and assigns, the �Company�), each other then existing Guarantor under the Indenture referred to below (the �Notes . . .
2563776
| | |
| Full Doc
 | 2005 |
Joinder Agreement
Joinder Agreement (2K)
Doc #1244210: This document is immediately available for purchase, but does not have a preview available for viewing.
1244210
| | |
| Preview
Full Doc
 | 2005 |
Letter of Transmittal
Letter of Transmittal (62K)
Doc #1244239: Click preview link for longer preview.
LETTER OF TRANSMITTAL
OFFER TO EXCHANGE ALL OF THE OUTSTANDING
8�% SENIOR SUBORDINATED NOTES DUE 2015
FOR
8�% SENIOR SUBORDINATED NOTES DUE 2015
REGISTERED UNDER THE SECURITIES ACT OF 1933
OF
WARNER CHILCOTT CORPORATION
THE EXCHANGE OFFER WILL EXPIRE AT [INSERT TIME OF DAY � 5:00 P.M. OR 12:01 A.M.], NEW YORK CITY TIME, ON [INSERT DATE THAT IS 20 FULL BUSINESS DAYS AFTER THE COMMENCEMENT DATE], UNLESS EXTENDED BY WARNER CHILCOTT CORPORATION (THE �TIME OF EXPIRATION�)
The Exchange Agent for the Exchange Offer is:
Wells Fargo Bank, National . . .
1244239
| | |
| Preview
Full Doc
 | 2005 |
Management Shareholders Agreement
Management Shareholders Agreement (194K)
Doc #1244209: Click preview link for longer preview.
MANAGEMENT SHAREHOLDERS AGREEMENT
DATED AS OF
MARCH 28, 2005
AMONG
WARNER CHILCOTT HOLDINGS COMPANY, LIMITED
WARNER CHILCOTT HOLDINGS COMPANY II, LIMITED
WARNER CHILCOTT HOLDINGS COMPANY III, LIMITED
THE MANAGEMENT SHAREHOLDERS PARTY HERETO
AND
THE OTHER PARTIES HERETO
TABLE OF CONTENTS
Page
ARTICLE 1 DEFINITIONS
1
Section 1.01
. . .
1244209
| |
DLJ LBO Plans
As referenced in this Management Shareholders Agreement:
DLJ LBO Plans Management – C.V.
By:
Name:
Title:
MILLENNIUM PARTNERS II, L.P.
By: DLJ Merchant Banking III, Inc., its Managing General Partner
By:
Name:
Title:
MBP III PLAN INVESTORS, L.P.
By: DLJ LBO Plans Management Corporation II, its General Partner
By:
Name:
Title:
Signature Page: Management Shareholders Agreement
JPMP FUNDS:
J.P. MORGAN PARTNERS (BHCA), L.P.
By:
JPMP MASTER FUND MANAGER, L.P.,
its _____________
dt 1319205
|
| Preview
Full Doc
 | 2005 |
Option and License Agreement
Option and License Agreement (77K)
Doc #1244221: Click preview link for longer preview.
OPTION AND LICENSE AGREEMENT
This OPTION AND LICENSE AGREEMENT (this �Agreement�), dated as of March 24, 2004 (the �Effective Date�), is made by and between Barr Laboratories, Inc., a corporation organized and existing under the laws of Delaware (�Barr�), and Galen (Chemicals) Limited, a company organized and existing under the laws of the Republic of Ireland (�Galen�). Barr and Galen are each sometimes referred to individually as a �Party� and together as the �Parties.�
RECITALS
WHEREAS, Barr and Galen are pharmaceutical companies engaged in the marketing . . .
1244221
|
Barr Pharma
As referenced in this Option and License Agreement:
Barr Pharmaceuticals, Inc – satisfactory to Barr.
(b) On the Effective Date, Barr will deliver or cause to be delivered to Galen:
(i) a duly executed Supply Agreement;
(ii) a guarantee, duly executed by Barr Pharmaceuticals, Inc ., in the form attached hereto as Exhibit C; and
(iii) any other agreements or documents reasonably necessary to consummate the transactions contemplated hereby, in form and substance reasonably satisfactory _____________
Barr Pharmaceuticals, Inc – Release
See attached.
400 Chestnut Ridge Road
Seagoe Industrial Estate
Woodcliff Lake, NJ 07677
Craigavon BT63 5UA
201-930-3300
United Kingdom
44 (0) 28 3833 4974
NEWS RELEASE
CONTACTS:
Barr Pharmaceuticals, Inc .
Carol A. Cox
Tel:
201-930-3720
email:
ccox@barrlabs.com
Galen Holdings PLC
David Kelly
Tel:
44 (0) 28 3836 3634
Sr. Vice President, Finance and Planning
email:
_____________
Barr Pharmaceuticals, Inc – License Barrs Generic Ovcon 35 Oral Contraceptive; Parties Continue to Negotiate Settlement of Outstanding Patent Challenges on Estrostep and femhrt
Woodcliff Lake, NJ and Craigavon, Northern Ireland - March 25, 2004 Barr Pharmaceuticals, Inc . (NYSE: BRL) and Galen Holdings PLC (LSE: GAL.L, NASDAQ: GALN) today announced that they have completed an agreement under which Barr Pharmaceuticals subsidiary, Duramed Pharmaceuticals, Inc., has acquired _____________
Barr Pharmaceuticals, Inc – made a $1 million payment to Barr Laboratories upon signing the option agreement and would pay Barr an additional $19 million at the time of the exercise of the option.
Barr Pharmaceuticals, Inc . is engaged through its subsidiaries in the development, manufacture and marketing of generic and proprietary pharmaceuticals.
Galen is a specialty pharmaceutical company based in Craigavon, Northern Ireland and Rockaway, _____________
Barr Pharmaceuticals, Inc – research and development, sales and marketing activities and patent challenge activities; and other risks detailed from time to time in our filings with the Securities and Exchange Commission.
[EDITORS ADVISORY: Barr Pharmaceuticals, Inc . news releases are available free of charge through PR Newswires News On-Call fax service. For a menu of Barrs previous releases, or to receive a specific release via _____________
dt 1383138
;
|
Galen Holdings
As referenced in this Option and License Agreement:
Galen Holdings PLC, – Effective Date.
(a) On the Effective Date, Galen will deliver or cause to be delivered to Barr:
(i) a duly executed Supply Agreement;
- 4 -
(ii) a guarantee, duly executed by Galen Holdings PLC, in the form attached hereto as Exhibit B; and
(iii) any other agreements or documents reasonably necessary to consummate the transactions contemplated hereby, in form and substance reasonably satisfactory _____________
Galen Holdings PLC, – REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, EITHER IN FACT OR BY OPERATION OF APPLICABLE LAW.
ARTICLE 6
CONFIDENTIALITY
6.1 Confidentiality. The Mutual Confidentiality Agreement between Barr Laboratories, Inc. and Galen Holdings PLC, dated as of April 25, 2002 (the Confidentiality Agreement), shall remain in full force and effect, the terms of which are hereby incorporated by reference, as amended and/or _____________
Galen Holdings PLC – be addressed to:
Galen (Chemicals) Limited
4 Adelaide Street
Dun Laoghaire, Co. Dublin
Ireland
Attention: Senior Vice President, Finance
Facsimile No.: 011-33-1-214-8477
With a copy to
Galen Holdings PLC
c/o Warner Chilcott, Inc.
100 Enterprise Drive
Rockaway, NJ 07866
Attention: Executive Vice President,
Corporate Development and General Counsel
Facsimile No.: +1 (973) 442-3316
Either Party may _____________
Galen Holdings PLC – 5.1(g)
Proceedings
1.
Investigations by the FTC relating to the (1) letter dated December 16, 2003 from Andrew S. Ginsburg of the FTC to Anthony D. Bruno of Galen Holdings PLC and (2) letter dated February 17, 2004 from Bradley S. Albert of the FTC to Charles E. Koob of Simpson Thacher & Bartlett LLP.
Schedule 5.2
ANDA Applications; Exceptions
_____________
Galen Holdings PLC
– Craigavon BT63 5UA
201-930-3300
United Kingdom
44 (0) 28 3833 4974
NEWS RELEASE
CONTACTS:
Barr Pharmaceuticals, Inc.
Carol A. Cox
Tel:
201-930-3720
email:
ccox@barrlabs.com
Galen Holdings PLC
David Kelly
Tel:
44 (0) 28 3836 3634
Sr. Vice President, Finance and Planning
email:
david.kelly@galenplc.com
Financial Dynamics
Tel:
44 (0) 207 831 3113
Francetta Carr
_____________
dt 1350764
;
Simpson Thacher
As referenced in this Option and License Agreement:
Simpson Thacher – of the FTC to Anthony D. Bruno of Galen Holdings PLC and (2) letter dated February 17, 2004 from Bradley S. Albert of the FTC to Charles E. Koob of Simpson Thacher & Bartlett LLP.
Schedule 5.2
ANDA Applications; Exceptions
ANDA No. 76-198
ANDA No. 76-238
Schedule 6.4
Press Release
See attached.
400 Chestnut Ridge Road
Seagoe _____________
dt 1529679
|
| Preview
Full Doc
 | 2005 |
Purchase and Sale Agreement
Purchase and Sale Agreement (174K)
Doc #1244219: Click preview link for longer preview.
Execution Version
PURCHASE AND SALE AGREEMENT
dated as of
May 3, 2004
among
PFIZER INC.,
PFIZER PHARMACEUTICALS LLC
GALEN HOLDINGS PUBLIC LIMITED COMPANY
and
WARNER CHILCOTT COMPANY, INC.
Table of Contents
Page
ARTICLE I DEFINITIONS AND TERMS
1
Section 1.1.
Definitions
1
Section 1.2.
Other Definitional . . .
1244219
|
Galen Holdings
As referenced in this Purchase and Sale Agreement:
GALEN HOLDINGS PLC – INC.
235 East 42nd Street
New York, NY 10017
Telephone: 212-733-4935
Facsimile: 212-808-8924
Attn: Senior Vice President &
General Counsel
If to Purchaser or Galen, to:
GALEN HOLDINGS PLC
100 Enterprise Drive
38
Rockaway, New Jersey 07866
Telephone: (973) 442-3371
Facsimile: (973) 442-3316
Attn: Executive Vice President, Corporate Development,
General Counsel and Corporate Secretary
With a _____________
dt 1350763
;
|
Pfizer
As referenced in this Purchase and Sale Agreement:
PFIZER INC – 3 20 dex103.htm PURCHASE AND SALE AGREEMENT, DATED AS OF MAY 3, 2004
Exhibit 10.3
Execution Version
PURCHASE AND SALE AGREEMENT
dated as of
May 3, 2004
among
PFIZER INC .,
PFIZER PHARMACEUTICALS LLC
GALEN HOLDINGS PUBLIC LIMITED COMPANY
and
WARNER CHILCOTT COMPANY, INC.
Table of Contents
Page
ARTICLE I DEFINITIONS AND TERMS
1
Section 1.1.
Definitions
1
Section _____________
Pfizer Inc – D.
Form of Transitional Supply Agreement
E.
Description of Land
PURCHASE AND SALE AGREEMENT
This Purchase and Sale Agreement is made and entered into as of May 3, 2004 among Pfizer Inc ., a Delaware corporation (Pfizer), Pfizer Pharmaceuticals LLC, a Delaware limited liability company (PPLLC, and together with Pfizer, the Sellers), Galen Holdings Public Limited Company, a public limited company organized _____________
PFIZER INC – ARTICLE X
MISCELLANEOUS
Section 10.1. Notices. All notices or other communications hereunder shall be made in writing (including facsimile transmission) and shall be given:
If to any Seller, to:
PFIZER INC .
235 East 42nd Street
New York, NY 10017
Telephone: 212-733-4935
Facsimile: 212-808-8924
Attn: Senior Vice President &
General Counsel
If to Purchaser or Galen, to:
_____________
PFIZER INC – this Agreement.
Remainder of Page Intentionally Left Blank
41
IN WITNESS WHEREOF, the parties have executed or caused this Agreement to be executed as of the date first written above.
PFIZER INC .
By:
/s/ John W. Mitchell
Name:
John W. Mitchell
Title:
Senior Vice President; President,
Pfizer Global Manufacturing
PFIZER PHARMACEUTICALS LLC
By:
/s/ John W. Mitchell
Name:
John W. Mitchell
_____________
Pfizer Inc – D
Transitional Supply Agreement
Exhibit E
Description of Land
DISCLOSURE SCHEDULES
This document contains the schedules (the Schedules) to the Purchase and Agreement, dated as of May 3, 2004, among Pfizer Inc ., Pfizer Pharmaceuticals Limited Liability Company, Galen Holdings Public Limited Company and Warner Chilcott Company, Inc. (the Agreement). The disclosure of any matter on any Schedule shall expressly not be _____________
dt 1334605
;
Simpson Thacher
As referenced in this Purchase and Sale Agreement:
Simpson Thacher – Enterprise Drive
38
Rockaway, New Jersey 07866
Telephone: (973) 442-3371
Facsimile: (973) 442-3316
Attn: Executive Vice President, Corporate Development,
General Counsel and Corporate Secretary
With a copy to:
Simpson Thacher & Bartlett
425 Lexington Avenue
New York, NY 10017
Telephone: (212) 455-7113
Facsimile: (212) 455-2502
Attn: Gary Horowitz, Esq.
All such notices and other communications shall be _____________
dt 1529678
|
| Preview
Full Doc
 | 2005 |
Registration Rights Agreement
Registration Rights Agreement (93K)
Doc #1244204: Click preview link for longer preview.
$600,000,000
WARNER CHILCOTT CORPORATION
8 3/4% Senior Subordinated Notes due 2015
REGISTRATION RIGHTS AGREEMENT
January 18, 2005
Credit Suisse First Boston LLC
Deutsche Bank Securities Inc.
J.P. Morgan Securities Inc.
As Representatives of the Several Purchasers,
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue,
New York, New York 10010-3629
Dear Sirs:
Warner Chilcott Corporation, a Delaware corporation formerly known as Warner Intermediate . . .
1244204
|
CSFB LLC
As referenced in this Registration Rights Agreement:
Credit Suisse First Boston LLC – AGREEMENT DATED JAN. 18, 2005
Exhibit 4.2
EXECUTION COPY
$600,000,000
WARNER CHILCOTT CORPORATION
8 3/4% Senior Subordinated Notes due 2015
REGISTRATION RIGHTS AGREEMENT
January 18, 2005
Credit Suisse First Boston LLC
Deutsche Bank Securities Inc.
J.P. Morgan Securities Inc.
As Representatives of the Several Purchasers,
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue,
New York, New York _____________
Credit Suisse First Boston LLC – due 2015
REGISTRATION RIGHTS AGREEMENT
January 18, 2005
Credit Suisse First Boston LLC
Deutsche Bank Securities Inc.
J.P. Morgan Securities Inc.
As Representatives of the Several Purchasers,
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue,
New York, New York 10010-3629
Dear Sirs:
Warner Chilcott Corporation, a Delaware corporation formerly known as Warner Intermediate Company, Inc. (the Issuer), proposes to issue _____________
Credit Suisse First Boston LLC – Avenue,
New York, New York 10010-3629
Dear Sirs:
Warner Chilcott Corporation, a Delaware corporation formerly known as Warner Intermediate Company, Inc. (the Issuer), proposes to issue and sell to Credit Suisse First Boston LLC (CSFBL), Deutsche Bank Securities Inc., J.P. Morgan Securities Inc. (JPMorgan) and Morgan Stanley & Co. Incorporated (collectively, the Purchasers), upon the terms set forth in a purchase agreement _____________
Credit Suisse First Boston LLC – guarantees overnight delivery:
(1) if to a Holder of the Securities, at the most current address given by such Holder to the Company;
(2) if to the Purchasers;
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010-3629
Fax No.: (212) 325-8278
Attention: Transactions Advisory Group
with a copy to:
Cravath, Swaine & Moore LLP
Worldwide Plaza
825 _____________
Credit Suisse First Boston LLC – amp; Moore LLP
Worldwide Plaza
825 Eighth Avenue
New York, NY 10019-7475
Fax No.: (212) 474-3700
Attention: George A. Stephanakis, Esq.
(3) if to CSFBL as Market-Maker:
Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010
Fax No.: (212) 325-8278
Attention: Transactions Advisory Group
with a copy to:
Cravath, Swaine & Moore LLP
825 Eighth Avenue
New _____________
dt 1351341
;
Deutsche Bank
As referenced in this Registration Rights Agreement:
Deutsche Bank Securities Inc – Exhibit 4.2
EXECUTION COPY
$600,000,000
WARNER CHILCOTT CORPORATION
8 3/4% Senior Subordinated Notes due 2015
REGISTRATION RIGHTS AGREEMENT
January 18, 2005
Credit Suisse First Boston LLC
Deutsche Bank Securities Inc .
J.P. Morgan Securities Inc.
As Representatives of the Several Purchasers,
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue,
New York, New York 10010-3629
Dear Sirs:
_____________
Deutsche Bank Securities Inc – 3629
Dear Sirs:
Warner Chilcott Corporation, a Delaware corporation formerly known as Warner Intermediate Company, Inc. (the Issuer), proposes to issue and sell to Credit Suisse First Boston LLC (CSFBL), Deutsche Bank Securities Inc ., J.P. Morgan Securities Inc. (JPMorgan) and Morgan Stanley & Co. Incorporated (collectively, the Purchasers), upon the terms set forth in a purchase agreement of even date herewith (the _____________
DEUTSCHE BANK SECURITIES INC – D. Bruno
Title:
Executive Vice President and Secretary
The foregoing Registration
Rights Agreement is hereby confirmed
and accepted as of the date first
above written.
CREDIT SUISSE FIRST BOSTON LLC
DEUTSCHE BANK SECURITIES INC .
J.P. MORGAN SECURITIES INC.
MORGAN STANLEY & CO. INCORPORATED
Acting on behalf of
themselves and as the Representatives
of several Purchasers.
By:
CREDIT SUISSE FIRST BOSTON LLC
By:
/ _____________
DEUTSCHE BANK SECURITIES INC – on behalf of
themselves and as the Representatives
of several Purchasers.
By:
CREDIT SUISSE FIRST BOSTON LLC
By:
/s/ EDWARD M. YORKe
Name:
Edward M. Yorke
Title:
Managing Director
By:
DEUTSCHE BANK SECURITIES INC .
By:
/s/ VIKRANT SAWBURY
Name:
Vikrant Sawbury
Title:
Director
By:
/s/ SEAN MAHANEY
Name:
Sean Mahaney
Title:
Managing Director
By:
J.P. MORGAN SECURITIES INC.
By:
/s/ JAMES MCHALE
_____________
dt 1376716
;
|
J.P. Morgan
As referenced in this Registration Rights Agreement:
J.P. Morgan Securities Inc – COPY
$600,000,000
WARNER CHILCOTT CORPORATION
8 3/4% Senior Subordinated Notes due 2015
REGISTRATION RIGHTS AGREEMENT
January 18, 2005
Credit Suisse First Boston LLC
Deutsche Bank Securities Inc.
J.P. Morgan Securities Inc .
As Representatives of the Several Purchasers,
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue,
New York, New York 10010-3629
Dear Sirs:
Warner Chilcott Corporation, a Delaware _____________
J.P. Morgan Securities Inc – Chilcott Corporation, a Delaware corporation formerly known as Warner Intermediate Company, Inc. (the Issuer), proposes to issue and sell to Credit Suisse First Boston LLC (CSFBL), Deutsche Bank Securities Inc., J.P. Morgan Securities Inc . (JPMorgan) and Morgan Stanley & Co. Incorporated (collectively, the Purchasers), upon the terms set forth in a purchase agreement of even date herewith (the Purchase Agreement), U.S. $600, _____________
J.P. Morgan Securities Inc – Cravath, Swaine & Moore LLP
825 Eighth Avenue
New York, NY 10019-7475
Fax No.: (212) 474 - 3700
Attention: George A. Stephanakis, Esq.
(4) if to JPMorgan as Market-Maker:
J.P. Morgan Securities Inc .
270 Park Avenue
New York, NY 10017
Fax No.: (212) 270-1063
Attention: Timothy Collins
with a copy to:
Cravath, Swaine & Moore LLP
825 Eighth Avenue
New York, _____________
J.P. MORGAN SECURITIES INC – Vice President and Secretary
The foregoing Registration
Rights Agreement is hereby confirmed
and accepted as of the date first
above written.
CREDIT SUISSE FIRST BOSTON LLC
DEUTSCHE BANK SECURITIES INC.
J.P. MORGAN SECURITIES INC .
MORGAN STANLEY & CO. INCORPORATED
Acting on behalf of
themselves and as the Representatives
of several Purchasers.
By:
CREDIT SUISSE FIRST BOSTON LLC
By:
/s/ EDWARD M. YORKe
Name:
_____________
J.P. MORGAN SECURITIES INC – M. Yorke
Title:
Managing Director
By:
DEUTSCHE BANK SECURITIES INC.
By:
/s/ VIKRANT SAWBURY
Name:
Vikrant Sawbury
Title:
Director
By:
/s/ SEAN MAHANEY
Name:
Sean Mahaney
Title:
Managing Director
By:
J.P. MORGAN SECURITIES INC .
By:
/s/ JAMES MCHALE
Name:
James McHale
Title:
VP
SCHEDULE A
Guarantors
Name
Jurisdiction of
Incorporation
Warner Chilcott Holdings Company III, Limited
Bermuda
Warner Chilcott Intermediate (Luxembourg) S. r. _____________
dt 1493664
;
Cravath
As referenced in this Registration Rights Agreement:
Cravath, Swaine – shall bear all fees and expenses incurred in connection with the performance of its obligations under Sections 1 through 4 hereof (including the reasonable fees and expenses, if any, of Cravath, Swaine & Moore LLP, counsel for the Purchasers, incurred in connection with the Registered Exchange Offer), whether or not the Exchange Offer Registration Statement or a Shelf Registration is filed _____________
Cravath, Swaine – the Purchasers;
c/o Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010-3629
Fax No.: (212) 325-8278
Attention: Transactions Advisory Group
with a copy to:
Cravath, Swaine & Moore LLP
Worldwide Plaza
825 Eighth Avenue
New York, NY 10019-7475
Fax No.: (212) 474-3700
Attention: George A. Stephanakis, Esq.
(3) if to CSFBL as Market- _____________
Cravath, Swaine – to CSFBL as Market-Maker:
Credit Suisse First Boston LLC
Eleven Madison Avenue
New York, NY 10010
Fax No.: (212) 325-8278
Attention: Transactions Advisory Group
with a copy to:
Cravath, Swaine & Moore LLP
825 Eighth Avenue
New York, NY 10019-7475
Fax No.: (212) 474 - 3700
Attention: George A. Stephanakis, Esq.
(4) if to JPMorgan as Market-Maker:
J. _____________
Cravath, Swaine – if to JPMorgan as Market-Maker:
J.P. Morgan Securities Inc.
270 Park Avenue
New York, NY 10017
Fax No.: (212) 270-1063
Attention: Timothy Collins
with a copy to:
Cravath, Swaine & Moore LLP
825 Eighth Avenue
New York, NY 10019-7475
Fax No.: (212) 474-3700
Attention: George A. Stephanakis, Esq.
18
(5) if to the Company, at its _____________
dt 1346202
;
Weil Gotshal
As referenced in this Registration Rights Agreement:
Weil, Gotshal – if to the Company, at its address as follows:
Warner Chilcott Corporation
100 Enterprise Drive
Rockaway, NJ 07866
Fax No.: (973) 442-3283
Attention: General Counsel
with a copy to:
Weil, Gotshal & Manges LLP
767 Fifth Avenue
New York, NY 10153-0119
Fax No.: (212) 310-8007
Attention: Matthew D. Bloch, Esq.
All such notices and communications shall be deemed _____________
dt 1366764
|
| Preview
Full Doc
 | 2006 |
Right of First Refusal Agreement
Right of First Refusal Agreement (23K)
Doc #1244175: Click preview link for longer preview.
Right of First Refusal
Agreement
between
WARNER CHILCOTT COMPANY, INC., of P.O. Box 1005, Fajardo, Puerto Rico, 00738 (�WCCI�)
and
LEO PHARMA A/S, of Industriparken 55, DK-2750 Ballerup, Denmark (�LEO�)
(collectively, the �Parties� and individually a �Party�).
Capitalized terms not otherwise defined herein shall have the meanings set forth in Article 1 of this Right of First Refusal Agreement (this �Agreement�).
WHEREAS the Parties are interested in collaborating on the development and marketing of certain products in the Territory,
WHEREAS the Parties have entered into a . . .
1244175
| | |
| Preview
Full Doc
 | 2005 |
Securities Purchase Agreement
Securities Purchase Agreement (30K)
Doc #1244217: Click preview link for longer preview.
SECURITIES PURCHASE AGREEMENT
THIS AGREEMENT is made as of January 18, 2005 (the �Agreement�), by and among Warner Chilcott Holdings Company, Limited, a Bermuda exempted limited company (together with its successors, �Holdings I�), Warner Chilcott Holdings Company II, Limited, a Bermuda exempted limited company (together with its successors, �Holdings II�, and collectively with Holdings I, the �Companies�), Bain Capital Integral Investors II, L.P., BCIP Trust Associates III, BCIP Trust Associates III-B, BCIP Associates � G (together with any of their respective affiliated . . .
1244217
| | |